ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.010
-0.050 (-4.72%)
At close: Mar 27, 2026, 4:00 PM EDT
1.000
-0.010 (-0.99%)
After-hours: Mar 27, 2026, 4:10 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $24.71 million as of March 27, 2026. Its market cap has increased by 177.64% in one year.
Market Cap
24.71M
Enterprise Value
27.44M
1-Year Change
177.64%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $24.71M, a decrease of -68.92%. That is a compound annual growth rate of -22.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 25.40M | -50.97% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 27.02M |
| Longeveron | 26.94M |
| Lixte Biotechnology Holdings | 26.92M |
| Kyntra Bio | 26.67M |
| CEL-SCI | 25.90M |
| Boundless Bio | 24.87M |
| Dyadic International | 24.73M |
| IGC Pharma | 24.46M |